4.0
22. Feb. 2014
Mitarbeiter (anonym)
Ehemaliger Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Top in their niche well over any closest competitor in technology and innovation.
Kontras
Only truly challenge was the times they were sold twice and now it seems they have a solid footing with Omnicell. Still need to advance more in Multi-med compliance packaging to the retail and closed-door segments.